Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma

Published on Sep 19, 2016in Journal of Clinical Oncology32.956
· DOI :10.1200/JCO.2015.61.4925
Daniel R. Wahl15
Estimated H-index: 15
(UM: University of Michigan),
Matthew H. Stenmark16
Estimated H-index: 16
+ 5 AuthorsMary Feng34
Estimated H-index: 34
PurposeData guiding selection of nonsurgical treatment of hepatocellular carcinoma (HCC) are lacking. We therefore compared outcomes between stereotactic body radiotherapy (SBRT) and radiofrequency ablation (RFA) for HCC.Patients and MethodsFrom 2004 to 2012, 224 patients with inoperable, nonmetastatic HCC underwent RFA (n = 161) to 249 tumors or image-guided SBRT (n = 63) to 83 tumors. We applied inverse probability of treatment weighting to adjust for imbalances in treatment assignment. Freedom from local progression (FFLP) and toxicity were retrospectively analyzed.ResultsRFA and SBRT groups were similar with respect to number of lesions treated per patient, type of underlying liver disease, and tumor size (median, 1.8 v 2.2 cm in maximum diameter; P = .14). However, the SBRT group had lower pretreatment Child-Pugh scores (P = .003), higher pretreatment alpha-fetoprotein levels (P = .04), and a greater number of prior liver-directed treatments (P < .001). One- and 2-year FFLP for tumors treated with RF...
Figures & Tables
📖 Papers frequently viewed together
492 Citations
14 Authors (Jin Kyu Kang, ..., Young Han Kim)
222 Citations
304 Citations
#1Ryan T. Groeschl (MCW: Medical College of Wisconsin)H-Index: 23
#2Charles H.C. Pilgrim (MCW: Medical College of Wisconsin)H-Index: 15
Last. T. Clark Gamblin (MCW: Medical College of Wisconsin)H-Index: 54
view all 18 authors...
OBJECTIVE: This study hypothesized that tumor size, number of tumors, surgical approach, and tumor histology significantly affected microwave ablation (MWA) success and recurrence-free survival. BACKGROUND: Although many hepatobiliary centers have adopted MWA, the factors that influence local control are not well described. METHODS: Consecutive patients with hepatic malignancy treated by MWA were included from 4 high-volume institutions (2003-2011) and grouped by histology: hepatocellular carcin...
158 CitationsSource
#1Atsuya TakedaH-Index: 27
#2Naoko SanukiH-Index: 25
Last. Etsuo Kunieda (Tokai University)H-Index: 34
view all 10 authors...
Background and Aims Stereotactic ablative body radiotherapy (SABR) is a relatively new treatment for hepatocellular carcinoma (HCC). The outcomes of SABR for previously untreated solitary HCC unfit for ablation and surgical resection were evaluated. Methods Untreated solitary HCC patients treated with SABR were retrospectively studied. Between 2005 and 2012, 221 HCC patients underwent SABR. Among them, patients with untreated solitary HCC, treated with only SABR or SABR preceded by transarterial...
60 CitationsSource
#1Rebecca L. SiegelH-Index: 67
#2Jiemin MaH-Index: 25
Last. Ahmedin JemalH-Index: 139
view all 4 authors...
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data were collected by the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data were collected by the National Center for Health Statistics. A total of 1,66...
9,298 CitationsSource
#1Z. Allibhai (Princess Margaret Cancer Centre)H-Index: 2
#2M. TaremiH-Index: 9
Last. B.C. John Cho (Princess Margaret Cancer Centre)H-Index: 22
view all 7 authors...
Purpose Stereotactic body radiation therapy for medically inoperable early-stage non-small cell lung cancer (NSCLC) offers excellent control rates. Most published series deal mainly with small (usually Methods and Materials Between October 2004 and October 2010, 185 medically inoperable patients with early (T1-T2N0M0) NSCLC were treated on a prospective research ethics board-approved single-institution protocol. Prescription doses were risk-adapted based on tumor size and location. Follow-up inc...
85 CitationsSource
#1Sang Min Yoon (UOU: University of Ulsan)H-Index: 25
#2Young-Suk Lim (UOU: University of Ulsan)H-Index: 58
Last. Jong Hoon Kim (UOU: University of Ulsan)H-Index: 39
view all 14 authors...
Background Even with early stage hepatocellular carcinoma (HCC), patients are often ineligible for surgical resection, transplantation, or local ablation due to advanced cirrhosis, donor shortage, or difficult location. Stereotactic body radiation therapy (SBRT) has been established as a standard treatment option for patients with stage I lung cancer, who are not eligible for surgery, and may be a promising alternative treatment for patients with small HCC who are not eligible for curative treat...
111 CitationsSource
#1Erqi Liu (UM: University of Michigan)H-Index: 3
#2Matthew H. Stenmark (UM: University of Michigan)H-Index: 16
Last. Mary Feng (UM: University of Michigan)H-Index: 34
view all 10 authors...
OBJECTIVES: The full potential of stereotactic body radiation therapy (SBRT), in the treatment of unresectable intrahepatic malignancies, has yet to be realized as our experience is still limited. Thus, we evaluated SBRT outcomes for primary and metastatic liver tumors, with the goal of identifying factors that may aid in optimization of therapy. METHODS: From 2005 to 2010, 62 patients with 106 primary and metastatic liver tumors were treated with SBRT to a median biologic effective dose (BED) o...
36 CitationsSource
#1Alexis Bujold (U of T: University of Toronto)H-Index: 5
#2Christine MasseyH-Index: 17
Last. Laura A. DawsonH-Index: 81
view all 14 authors...
Purpose To describe outcomes of prospective trials of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma (HCC). Patients and Methods Two trials of SBRT for patients with active HCC unsuitable for standard locoregional therapies were conducted from 2004 to 2010. All patients had Child-Turcotte-Pugh class A disease, with at least 700 mL of non-HCC liver. The SBRT dose range was 24 to 54 Gy in six fractions. Primary end points were toxicity and local control at 1 year (LC1y), define...
492 CitationsSource
#1Robert M. Cannon (University of Louisville)H-Index: 25
#2Susan Ellis (University of Louisville)H-Index: 13
Last. Robert C.G. Martin (University of Louisville)H-Index: 81
view all 5 authors...
Introduction Irreversible electroporation (IRE) has shown promise for ablation of lesions in proximity to vital structures in the preclinical setting. This study aims to evaluate the safety and efficacy of IRE for hepatic tumors in the clinical setting. Methods An IRB approved prospective registry of patients undergoing IRE for hepatic tumors over a 2-year period. Factors analyzed included patient and tumor characteristics, treatment related complications, and local recurrence free survival (LRF...
250 CitationsSource
#1Jung Hyun Kwon (Catholic University of Korea)H-Index: 15
#2Si Hyun Bae (Catholic University of Korea)H-Index: 34
Last. Kyu Won Chung (Catholic University of Korea)H-Index: 17
view all 9 authors...
Background We evaluated the long-term effect of stereotactic body radiation therapy (SBRT) for primary small hepatocellular carcinoma (HCC) ineligible for local therapy or surgery.
194 CitationsSource
#1Young Seok SeoH-Index: 15
#2Mi Sook KimH-Index: 19
Last. Dong Han LeeH-Index: 21
view all 11 authors...
Background and Objectives To evaluate the toxicity and efficacy of stereotactic body radiotherapy (SBRT) for the treatment of localized hepatocellular carcinoma (HCC) in the absence of another standard treatment option. Methods The authors reviewed the details of 38 patients with inoperable HCC (diameter <10 cm) treated by SBRT in a prospectively registered database at their institution. All patients had been treated by transcatheter arterial chemoembolization before SBRT, which had been finally...
120 CitationsSource
Cited By257
#1Xiaomeng DaiH-Index: 2
#2Jian Ruan (ZJU: Zhejiang University)H-Index: 3
Last. Peng ZhaoH-Index: 15
view all 15 authors...
Abstract Hypoxia represents a tremendous barrier for effective radiotherapy in hepatocellular carcinoma (HCC). Treatment strategies for improving hypoxia are of great significance to enhance radiotherapy efficacy. Here, we design polydopamine-nanoparticle-stabilized oxygen microcapsules by interfacial polymerization, which encapsulate oxygen in the core of polydopamine nanoparticle shell, exhibiting excellent biocompatibility and dispersity in aqueous solution. The oxygen microcapsules rapidly i...
#1Nima Nabavizadeh (OHSU: Oregon Health & Science University)H-Index: 14
#1Nima Nabavizadeh (OHSU: Oregon Health & Science University)H-Index: 3
Last. Khashayar Farsad (OHSU: Oregon Health & Science University)H-Index: 16
view all 9 authors...
Background: Transarterial chemoembolization (TACE) has synergistic properties when combined with ablative therapies for hepatocellular carcinoma (HCC). Objective: To compare outcomes for inoperable HCC between TACE with percutaneous thermal ablation (T-TA) and TACE with stereotactic body radiotherapy (T-SBRT) using propensity-score-weighted cohorts. Methods: This retrospective study included 190 patients with a single inoperable HCC treated from 2007 to 2018 by either T-SBRT (n=90) or T-TA (n=10...
2 CitationsSource
#1Mihir Shanker (UQ: University of Queensland)H-Index: 4
#2Pereshin Moodaley (Royal Brisbane and Women's Hospital)
Last. David Pryor (UQ: University of Queensland)H-Index: 13
view all 6 authors...
There is a growing body of literature supporting the use of stereotactic ablative body radiotherapy (SABR) in the management of primary hepatocellular carcinoma (HCC). This systematic review and meta-analysis of the current published evidence for SABR for HCC assessed the impact of treatment dose, fractionation and tumour size on the outcomes of local control (LC), overall survival (OS) and toxicity. A systematic search was independently performed by two authors for articles published in peer-re...
#1Zhijuan Yang (Soochow University (Suzhou))H-Index: 11
#2Yujie Zhu (Soochow University (Suzhou))H-Index: 4
Last. Zhuang Liu (MUST: Macau University of Science and Technology)H-Index: 147
view all 8 authors...
Radiofrequency ablation (RFA) is clinically adopted to destruct solid tumors, but is often incapable of completely ablating large tumors and those with multiple metastatic sites. Here we develop a CaCO3-assisted double emulsion method to encapsulate lipoxidase and hemin with poly(lactic-co-glycolic acid) (PLGA) to enhance RFA. We show the HLCaP nanoreactors (NRs) with pH-dependent catalytic capacity can continuously produce cytotoxic lipid radicals via the lipid peroxidation chain reaction using...
#2Bin QiuH-Index: 1
view all 8 authors...
Brachytherapy (BT), a type of focal anti-cancer radiotherapy, delivers a highly focused radiation dose to localized tumors, sparing surrounding normal tissues. Recent technological advances have helped to increase the accuracy of BT and, thus, improve BT-based cancer treatment. Stereotactic ablative brachytherapy (SABT) was designed to improve the ablative effect of radiation, which was achieved via improved image guidance, and calculation of ablative dose, shorter treatment duration, and better...
#1Yan Huang (Southern Medical University)H-Index: 1
#2Hailong Sheng (Southern Medical University)H-Index: 1
Last. Jingyuan Sun (Southern Medical University)H-Index: 4
view all 10 authors...
Abstract null null Background and purpose null Radiotherapy (RT) has a promising anti-tumor effect depending on its effects on both cancer cells and tumor immune microenvironment (TIME). As one of the most common alterations in hepatocellular carcinoma (HCC), wnt/β-catenin pathway activation, has been reported to induce radioresistance and suppressive TIME. In this study, we aim to explore the effect of wnt/β-catenin inhibitor ICG-001 on radiosensitivity and RT-related TIME of HCC and the underl...
#1Namita E. Mathew (Emory University)
#2Mohammad Elsayed (Emory University)H-Index: 5
Last. Nima Kokabi (Emory University)H-Index: 18
view all 8 authors...
#1Liang-Cheng ChenH-Index: 3
#2Hon-Yi LinH-Index: 10
Last. Moon-Sing LeeH-Index: 16
view all 5 authors...
#2Philip CamilleriH-Index: 1
view all 5 authors...